移植患者的免疫抑制:对全科医生进行更新
Bassam G Abu Jawdeh1, Hay Me Me1
1Division of Nephrology and Hypertension, Mayo Clinic Arizona, Phoenix, AZ.
Advances in kidney disease and health
|September 4, 2024
概括
移植免疫抑制已经取得了进展,但长期结果需要改进. 一个新的工具,iBOX,显示了作为未来临床试验评估移植存活的替代终点的承诺.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
背景情况:
- 移植是末期病的黄金标准.
- 目前的免疫抑制依赖于mycophenolate和calcineurin抑制剂,长期成功有限.
- 由于拒绝问题,替代性免疫抑制剂面临采用障碍.
研究的目的:
- 审查移植中具有里程碑意义的免疫抑制研究.
- 讨论免疫抑制协议的挑战和未来方向.
- 介绍iBOX作为移植存活的潜在代用终点.
主要方法:
- 对移植免疫抑制的里程碑性研究的综述.
- 讨论目前的挑战和未来的研究方向.
- 介绍了iBOX风险预测工具.
主要成果:
- 目前的免疫抑制方案改善了急性排斥,但不能改善长期的移植存活率.
- 替代性免疫抑制剂,如贝拉塔塞普和mTOR抑制剂的应用有限.
- 提议iBOX作为一个动态工具来预测长期死亡审查的移植失败.
结论:
- 需要改善移植免疫抑制的长期结果.
- 类固醇节约和氨酸抑制剂节约协议需要进一步调查.
- iBOX可以作为未来免疫抑制试验的有价值的替代终点.
相关概念视频
01:24Tissue Transplantation
346
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
346
01:40Cell-mediated Immune Responses
67.9K
Overview
67.9K
01:11Renal Failure: Dose Adjustments
69
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
69